Errata: Detection of Exosomal Biomarker by Electric Field-induced Release and Measurement (EFIRM)

DOI:

10.3791/5755

Nie opublikowano

W tym artykule

Podsumowanie

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

An erratum was issued for Detection of Exosomal Biomarker by Electric Field-induced Release and Measurement (EFIRM).

Streszczenie

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

An erratum was issued for Detection of Exosomal Biomarker by Electric Field-induced Release and Measurement (EFIRM). The disclosures were updated.

Protokół

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

An erratum was issued for Detection of Exosomal Biomarker by Electric Field-induced Release and Measurement (EFIRM). The disclosures were updated from:

David Wong is co-founder of RNAmeTRIX Inc., a molecular diagnostic company. PeriRx LLC sublicensed intellectual properties pertaining to molecular diagnostics from RNAmeTRIX. David Wong is a consultant to PeriRx.

to

David T. Wong is co-founder of RNAmeTRIX Inc., a molecular diagnostic company. He holds equity in RNAmeTRIX, and serves as a company director and scientific advisor. The University of California also holds equity in RNAmeTRIX. Intellectual property that David T. Wong invented and which was patented by the University of California has been licensed to RNAmeTRIX. Additionally, he is a paid consultant to PeriRx.

Oświadczenia

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,
No conflicts of interest declared.

Przedruki i uprawnienia

Poproś o pozwolenie na ponowne wykorzystanie tekstu lub ilustracji tego artykułu JoVE

Poproś o pozwolenie

Tagi

Wykrywanie biomarker wanaliza egzosom wprzy o enie pola elektrycznegopomiar biomarker wuwalnianie egzosom wmetoda detekcjianaliza biomarker w